Arlington Trust Co LLC Cuts Stock Position in The Procter & Gamble Company (NYSE:PG)

Arlington Trust Co LLC reduced its position in shares of The Procter & Gamble Company (NYSE:PG) by 8.3% in the 3rd quarter, HoldingsChannel reports. The firm owned 2,536 shares of the company’s stock after selling 230 shares during the period. Arlington Trust Co LLC’s holdings in Procter & Gamble were worth $439,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also modified their holdings of PG. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble during the 2nd quarter worth approximately $28,000. Fairway Wealth LLC acquired a new stake in Procter & Gamble in the second quarter valued at $29,000. Ruedi Wealth Management Inc. raised its stake in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares during the last quarter. POM Investment Strategies LLC purchased a new stake in Procter & Gamble in the 2nd quarter valued at approximately $34,000. Finally, Quest Partners LLC acquired a new position in shares of Procter & Gamble in the second quarter worth $36,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Jon R. Moeller sold 72,174 shares of the company’s stock in a transaction on Friday, August 9th. The stock was sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the completion of the sale, the chief executive officer now owns 263,158 shares in the company, valued at approximately $45,002,649.58. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Procter & Gamble news, CEO Jon R. Moeller sold 72,174 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $171.01, for a total transaction of $12,342,475.74. Following the sale, the chief executive officer now directly owns 263,158 shares of the company’s stock, valued at $45,002,649.58. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction on Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares in the company, valued at approximately $1,954,538.34. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 389,144 shares of company stock worth $66,184,385. 0.18% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on PG. DA Davidson upped their price objective on shares of Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a research note on Monday, October 21st. Jefferies Financial Group lowered Procter & Gamble from a “buy” rating to a “hold” rating and cut their price objective for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. TD Cowen assumed coverage on shares of Procter & Gamble in a research note on Tuesday, July 23rd. They set a “buy” rating and a $189.00 price objective on the stock. Morgan Stanley lifted their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a report on Monday, October 21st. Finally, Citigroup increased their price target on shares of Procter & Gamble from $177.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $177.00.

Procter & Gamble Stock Performance

NYSE PG traded down $0.08 during trading on Friday, hitting $165.10. 5,455,095 shares of the company’s stock traded hands, compared to its average volume of 6,645,703. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock has a market capitalization of $388.82 billion, a price-to-earnings ratio of 28.47, a PEG ratio of 3.59 and a beta of 0.41. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The business has a 50 day moving average of $171.62 and a 200-day moving average of $167.91.

Procter & Gamble (NYSE:PG) last released its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm’s quarterly revenue was down .6% compared to the same quarter last year. During the same quarter last year, the firm earned $1.83 EPS. As a group, equities research analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a yield of 2.44%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.48%.

Procter & Gamble Profile

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.